Can FDG-PET assess the response to chemotherapy and predict tissue necrosis in osteosarcoma and Ewing sarcoma?
Folia Med (Plovdiv)
; 66(2): 196-202, 2024 Apr 30.
Article
en En
| MEDLINE
| ID: mdl-38690814
ABSTRACT
INTRODUCTION:
Osteosarcoma (OS) and Ewing sarcoma (ES) represent the pediatric population's most common malignant bone tumors. 18-Fluorodeoxyglucose positron emission tomography has been shown to be effective in both the diagnostic and staging phases of cancer treatment. In recent years, some studies have also explored the possibility that FDG-PET could have a prognostic role.Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Sarcoma de Ewing
/
Neoplasias Óseas
/
Osteosarcoma
/
Radiofármacos
/
Fluorodesoxiglucosa F18
/
Tomografía de Emisión de Positrones
Idioma:
En
Revista:
Folia Med (Plovdiv)
Año:
2024
Tipo del documento:
Article